Search
for
Sort by
Research 331–360 of 1000+
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- EFFICACY AND SAFETY OF STANDARDIZED CINNAMON BARK EXTRACT FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED WEIGHT LOSS AND ALOPECIA IN PATIENTS WITH BREAST CANCER: A RANDOMIZED, DOUBLE-BLIND, AND PLACEBO-CONTROLLED STUDY
- Hair relaxer use and breast cancer risk by tumor molecular subtypes.
- Efficacy of Scalp Cooling combined with DHL-HisZnNa Lotion in the Prevention of Chemotherapy-Induced Alopecia in Patients with Breast Cancer
- The Effect of Social Support on the Empowerment Status and Alopecia‐Related Quality of Life in Breast Cancer Patients: A Cross‐Sectional Structural Equation Modeling Study
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer.
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- 203 Inhibin A is downregulated during chemotherapy in patients with breast cancer
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- Breast cancer in a transgender man
- 202 Activation of breast cancer cell proliferation by ROR-alpha through aromatase promoter
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Postmillennial breast cancer photo-narratives: Technologized terrain
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Anxiety, depression and quality of life in breast cancer patients undergoing chemotherapy in a tertiary care centre- a cross-sectional study
- Advanced Breast Cancer in Young Women
- Alopecia Neoplastica: A Manifestation of Metastatic Breast Cancer